NIKKEI 225
38,923.03 +435.13 (+1.13%) HANG SENG
18,403.04 +323.43 (+1.79%) CRUDE OIL
74.35 -2.64 (-3.43%) GOLD FUTURES
2,367.40 +21.60 (+0.92%) DOW
38,291.65 -394.67 (-1.02%) Bitcoin GBP
54,138.39 +916.53 (+1.72%)
LQDA Jul 2024 12.500 call
| Previous close | 2.0000 |
| Open | 2.5000 |
| Bid | 2.4500 |
| Ask | 3.2000 |
| Strike | 12.50 |
| Expiry date | 2024-07-19 |
| Day's range | 2.5000 - 3.4000 |
| Contract range | N/A |
| Volume | |
| Open interest | 447 |
Investor's Business DailyLiquidia Stock Surges After Winning Patent Battle Vs. United Therapeutics
Liquidia stock retook its 50-day line on a U.S. judge's ruling on a patent dispute with United Therapeutics.
GlobeNewswireDistrict Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ Launch
On May 31, Judge Andrews denied United Therapeutics’ motion for a preliminary injunction to block the launch of YUTREPIA in the PH-ILD indicationRuling reinforces the clear path for FDA to issue final decision on amended NDA for YUTREPIA to treat both PAH and PH-ILD MORRISVILLE, N.C., June 03, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that on May 31, Judge Andrews of the U.S. District Court for the District of Delaware (District Court) denied the motion for pre
- GlobeNewswire
Liquidia Corporation to Present at the 2024 Jefferies Global Healthcare Conference
MORRISVILLE, N.C., May 29, 2024 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Michael Kaseta, chief operating officer and chief financial officer, will provide an update on the company's business during a fireside chat at the 2024 Jefferies Global Healthcare Conference on Wednesday June 5, 2024, beginning at 9:00 a.m. ET, in New York City, NY.Access to a webcast will be available to investors and other interested parties by accessing Liquidia’s website at https://l
